患者モニタリング用装置の世界市場2020–2027:製品別(血行動態モニタリング、神経モニタリング、心臓モニタリング、胎児・新生児モニタリング、呼吸モニタリング、マルチパラメーターモニタリング、リモート患者モニタリング、体重モニタリング、温度モニタリングデバイス)、エンドユーザー別

◆英語タイトル:Patient Monitoring Devices Market by Product Type (Hemodynamic Monitoring, Neuromonitoring, Cardiac Monitoring, Fetal & Neonatal Monitoring, Respiratory Monitoring, Multi-Parameter Monitoring, Remote Patient Monitoring, Weigh Monitoring, And Temperature Monitoring Devices) and End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2020–2027
◆商品コード:AMR20SP034
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2020年7月
◆ページ数:319
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,769 ⇒換算¥623,052見積依頼/購入/質問フォーム
5 UserUSD6,450 ⇒換算¥696,600見積依頼/購入/質問フォーム
Enterprise UserUSD8,995 ⇒換算¥971,460見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは患者モニタリング用装置の世界市場について詳細に調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、製品別(血行動態モニタリング装置、神経モニタリング装置、心臓モニタリング装置、胎児新生児モニタリング装置)分析、エンドユーザー別(病院、ホーム設定、外来手術センター(ASC))分析、地域別分析、企業情報など、今後の市場展望をまとめております。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・患者モニタリング用装置の世界市場規模:製品別(血行動態モニタリング装置、神経モニタリング装置、心臓モニタリング装置、胎児新生児モニタリング装置)
・患者モニタリング用装置の世界市場規模:エンドユーザー別(病院、ホーム設定、外来手術センター(ASC))
・患者モニタリング用装置の世界市場規模:地域別
・企業情報
【レポートの概要】

The global patient monitoring devices market was $25,768.56 million in 2019, and is projected to reach $44,861.56 million by 2027 at a CAGR of 4.4% from 2020 to 2027.
Patient monitoring devices are used to observe vital signs such as respiration and heart rate of patients. With advancements in wireless technology, these devices can be used remotely to monitor physiological parameters of patients. Patient monitoring devices such as pulse oximeters, capnographs, and cardiac monitors are increasingly being used in hospitals, clinics, and various outpatient centers. These devices are commonly used during minor and major surgeries to monitor physiological signs of patients and intervene, if any complication occurs. These devices can also help healthcare professionals to monitor vital signs of multiple patients at the same time. Some of these devices are also used to alert physicians, in case the parameter levels are either above or below the limit set by physicians. Moreover, with the help of remote monitoring devices, physicians can remotely monitor physiological parameters such as blood glucose level, blood pressure, and heart rate; and accordingly provide appropriate treatment for patients.

The market is expected to witness a significant growth during the forecast period. The growth can be attributed to increase in geriatric population and rise in adoption of remote patient monitoring devices. Rise in prevalence of patients suffering from different lifestyle diseases such as diabetes, cancer, and atherosclerosis also contribute toward the growth of the patient monitoring devices market. Moreover, collaborations between companies, hospitals, and academic institutions are expected to increase the market revenue and, therefore, boost the market growth. However, cost associated with these products and lack of awareness among patients hinders the market growth. Moreover, government regulations and reimbursement issues also restrain growth of the patient monitoring devices market.

The global patient monitoring devices market is segmented on the basis of product type, end user, and region. By product type, it is divided into hemodynamic monitoring, neuromonitoring, cardiac monitoring, fetal & neonatal monitoring, respiratory monitoring, multi-parameter monitoring, remote patient monitoring, weigh monitoring, and temperature monitoring devices. On the basis of end user it is segmented into hospitals, home settings, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• The report provides an extensive analysis of the current market trends and future estimations in the patient monitoring devices market.
• The market scenario is comprehensively analyzed with respect to the device types and end users.
• The market estimations are based on high-end analysis of the key developments from 2019-2027.
• Recent developments and key manufacturers are listed to understand the competitive market scenario.
• In-depth geographical analysis provides an understanding of the regional market, which assists in strategic business planning.

Key Market Segments
By Product
• Hemodynamic Monitoring Devices
o Blood Glucose
o Cholesterol
o Blood Gas & Electrolyte Analyzers/Monitors
o Blood Pressure

• Neuromonitoring Devices
o Electroencephalograph (EEG) Devices
o Transcranial Dopplers (TCD)
o Magnetoencephalography (MEG) Devices
o Intracranial Pressure Monitors (ICP)
o Cerebral Oximeters
• Cardiac Monitoring Devices
o Electrocardiogram (ECG) Devices
o Holter Monitor
o Event Monitors
o Others
• Fetal & Neonatal Monitoring Devices
o Ultrasound
o Electronic Fetal Monitoring Devices
o Fetal Doppler Monitoring Devices
o Other Fetal & Neonatal Monitoring Devices
• Respiratory Monitoring Devices
o Capnographs
o Spirometers
o Sleep Apnea Monitor
o Pulse Oximeters
• Multiparameter Monitoring Devices
o High Acuity
o Mid Acuity
o Low Acuity
• Remote Patient Monitoring Devices
• Weight Monitoring Devices
• Temperature Monitoring Devices

By End User
• Hospitals & Clinics
• Home Settings
• Ambulatory Surgical Centers (ASCs)

By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 UK
 Germany
 France
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 China
 Japan
 India
 Australia
 South Korea
 Rest of Asia-Pacific
o LAMEA
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Rest of LAMEA
List of key players profiled in the report
• Medtronic, Inc.
• Biotronik
• F. Hoffmann-La Roche Ltd.
• GE Healthcare Ltd
• Masimo Corporation
• Nihon Kohden Corporation
• Johnson and Johnson
• Omron Healthcare Co. Ltd.
• Abbott Laboratories
• Koninklijke Philips N.V.

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Top Player Positioning
3.4.Porter’s five forces analysis
3.5.COVID-19 impact on the market
3.6.Government regulations

3.6.1.U.S. FDA
3.6.2.European Conformity (CE) mark
3.6.3.Ministry of Health, Labor, and Welfare (MHLW)

3.7.Reimbursement scenarios
3.8.Clinical trials
3.9.Patent analysis

3.9.1.Patents Registered/Approved, 2011–2020
3.9.2.Patents Registered/Approved, by Applicants, 2011–2020
3.9.3.U.S. patent analysis, by market applicants
3.9.4.PCT patent analysis, by market applicants
3.9.5.Europe patent analysis, by market applicants
3.9.6.China patent analysis, by market applicants
3.9.7.Australia patent analysis by market applicants

3.10.Market Dynamics

3.10.1.Drivers

3.10.1.1.Rise in prevalence of lifestyle diseases
3.10.1.2.Increase in geriatric population
3.10.1.3.Rise in the adoption of remote patient monitoring devices

3.10.2.Restraints

3.10.2.1.Government regulations and reimbursement issues
3.10.2.2.Limited awareness and high costs

3.10.3.Opportunities

3.10.3.1.Untapped markets in developing countries
3.10.3.2.Technological advancements

CHAPTER 4:PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Hemodynamic monitoring devices

4.2.1.Key market trends and opportunity
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.2.4.Blood glucose monitors

4.2.4.1.Market size and forecast

4.2.5.Blood gas and electrolyte analyzers/monitors

4.2.5.1.Market size and forecast

4.2.6.Blood pressure monitors

4.2.6.1.Market size and forecast

4.3.Neuromonitoring devices

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
4.3.4.Electroencephalograph (EEG) devices

4.3.4.1.Market size and forecast

4.3.5.Transcranial dopplers (TCD)

4.3.5.1.Market size and forecast

4.3.6.Magnetoencephalograph (MEG) devices

4.3.6.1.Market size and forecast

4.3.7.Intracranial pressure monitors (ICP)

4.3.7.1.Market size and forecast

4.3.8.Cerebral oximeters

4.3.8.1.Market size and forecast

4.4.Cardiac monitoring devices

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast
4.4.3.Market share analysis, by country
4.4.4.Electrocardiogram (ECG) devices

4.4.4.1.By type
4.4.4.2.By lead type
4.4.4.3.Market size and forecast

4.4.5.Holter monitors

4.4.5.1.Market size and forecast

4.4.6.Event monitors

4.4.6.1.By type
4.4.6.2.By technology
4.4.6.3.Market size and forecast

4.4.7.Others (Implantable loop recorder, Cardiac output monitor and others)

4.4.7.1.Market size and forecast

4.5.Fetal neonatal monitoring devices

4.5.1.Key market trends and opportunities
4.5.2.Market size and forecast
4.5.3.Market share analysis, by country
4.5.4.Ultrasound

4.5.4.1.Market size and forecast

4.5.5.Electronic Fetal Monitoring Devices

4.5.5.1.Market size and forecast

4.5.6.Fetal Doppler Monitoring Devices

4.5.6.1.Market size and forecast

4.5.7.Others

4.5.7.1.Market size and forecast

4.6.Respiratory monitors

4.6.1.Key market trends and opportunities
4.6.2.Market size and forecast
4.6.3.Market share analysis, by country
4.6.4.Capnographs

4.6.4.1.Market size and forecast

4.6.5.Pulse oximeters

4.6.5.1.Market size and forecast

4.6.6.Sleep apnea monitors

4.6.6.1.Market size and forecast

4.6.7.Spirometers

4.6.7.1.Market size and forecast

4.7.Multiparameter monitoring devices

4.7.1.Key market trends and opportunities
4.7.2.Market size and forecast
4.7.3.Market share analysis, by country
4.7.4.High acuity

4.7.4.1.Market size and forecast

4.7.5.Mid acuity

4.7.5.1.Market size and forecast

4.7.6.Low acuity

4.7.6.1.Market size and forecast

4.8.Remote patient monitoring devices

4.8.1.Key market trends and opportunities
4.8.2.Market size and forecast
4.8.3.Market share analysis, by country

4.9.Weight monitoring devices

4.9.1.Key market trends and opportunities
4.9.2.Market size and forecast
4.9.3.Market share analysis, by country

4.10.Temperature monitoring devices

4.10.1.Key market trends and opportunities
4.10.2.Market size and forecast
4.10.3.Market share analysis, by country

4.11.Urine output monitoring

4.11.1.Key market trends and opportunities
4.11.2.Market size and forecast
4.11.3.Market share analysis, by country

CHAPTER 5:PATIENT MONITORING DEVICES MARKET, BY END USER

5.1.Overview

5.1.1.Market size and forecast

5.2.Hospitals

5.2.1.Market size and forecast
5.2.2.Market share analysis, by country

5.3.Home settings

5.3.1.Market size and forecast
5.3.2.Market share analysis, by country

5.4.Ambulatory surgical centers (ASCs)

5.4.1.Market size and forecast
5.4.2.Market share analysis, by country

CHAPTER 6:PATIENT MONITORING DEVICES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key opportunities and forecast
6.2.2.Market size and forecast

6.2.2.1.U.S. market size and forecast
6.2.2.2.Canada market size and forecast
6.2.2.3.Mexico market size and forecast

6.3.Europe

6.3.1.Key opportunities and forecast
6.3.2.Market size and forecast

6.3.2.1.Germany market size and forecast
6.3.2.2.France market size and forecast
6.3.2.3.UK market size and forecast
6.3.2.4.Italy market size and forecast
6.3.2.5.Spain market size and forecast
6.3.2.6.Rest of Europe market size and forecast

6.4.Asia-Pacific

6.4.1.Key opportunities and forecast
6.4.2.Market size and forecast

6.4.2.1.Japan market size and forecast
6.4.2.2.China market size and forecast
6.4.2.3.Australia market size and forecast
6.4.2.4.India market size and forecast
6.4.2.5.South Korea market size and forecast
6.4.2.6.Rest of Asia-Pacific market size and forecast

6.5.LAMEA

6.5.1.Key opportunities and forecast
6.5.2.Market size and forecast

6.5.2.1.Brazil market size and forecast
6.5.2.2.Turkey market size and forecast
6.5.2.3.Venezuela market size and forecast
6.5.2.4.Saudi Arabia market size and forecast
6.5.2.5.Rest of LAMEA market size and forecast

CHAPTER 7:COMPANY PROFILES

7.1.ABBOTT LABORATORIES

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments

7.2.BIOTRONIK SE & CO. KG

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments

7.3.GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments

7.4.F. HOFFMANN-LA ROCHE LTD.

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments

7.5.JOHNSON & JOHNSON

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.6.6.Key strategic moves and developments

7.7.MASIMO CORPORATION

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio
7.7.4.Business performance
7.7.5.Key Strategic Moves and Developments

7.8.MEDTRONIC PLC.

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Medtronic offers following patient monitoring devices
7.8.5.Business performance
7.8.6.Key strategic moves and developments

7.9.NIHON KOHDEN CORPORATION

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments

7.10.OMRON CORPORATION

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key Strategic Moves and Development

LIST OF TABLES

TABLE 01.CLINICAL TRIALS: PATIENT MONITORING DEVICES MARKET, 2013–2020
TABLE 02.PATENTS REGISTERED/APPROVED ACROSS THE GLOBE, 2011–2020
TABLE 03.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
TABLE 04.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011- 2020
TABLE 05.PCT PATENT ANALYSIS, BY APPLICANTS, 2011–2020
TABLE 06.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 07.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 08.AUSTRALIA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
TABLE 09.GLOBAL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027 ($MILLION)
TABLE 10.HEMODYNAMIC MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 11.HEMODYNAMIC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 12.BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 13.BLOOD GAS & ELECTROLYTE ANALYSERS MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 14.BLOOD PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 15.NEUROMONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 16.NEUROMONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 17.ELECTROENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 18.TRANSCRANIAL DOPPLERS MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 19.MAGNETOENCEPHALOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 20.INTRACRANIAL PRESSURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 21.CEREBRAL OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 22.CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 23.CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 24.ELECTROCARDIOGRAM MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 25.HOLTER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 26.EVENT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 27.OTHER CARDIAC MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 28.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 29.FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 30.ULTRASOUND MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 31.ELECTRONIC FETAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 32.FETAL DOPPLER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 33.OTHER FETAL AND NEONATAL MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 34.RESPIRATORY MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 35.RESPIRATORY MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 36.CAPNOGRAPH MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 37.PULSE OXIMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 38.SLEEP APNEA MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 39.SPIROMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 40.MULTIPARAMETER MONITORING DEVICES MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 41.MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 42.HIGH ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 43.MID ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 44.LOW ACUITY MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 45.REMOTE PATIENT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 46.WEIGHT MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 47.TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2019–2027 ($MILLION)
TABLE 48.PATIENT MONITORING DEVICES MARKET FOR URINE MONITORING DEVICES, BY REGION, 2019–2027 ($MILLION)
TABLE 49.GLOBAL PATIENT MONITORING DEVICES MARKET, BY END USER 2019–2027 ($MILLION)
TABLE 50.PATIENT MONITORING DEVICES MARKET IN HOSPITALS, BY REGION, 2019–2027 ($MILLION)
TABLE 51.PATIENT MONITORING DEVICES MARKET IN HOME SETTING, BY REGION, 2019–2027 ($MILLION)
TABLE 52.PATIENT MONITORING DEVICES MARKET IN AMBULATORY SURGICAL CENTERS, BY REGION, 2019–2027 ($MILLION)
TABLE 53.PATIENT MONITORING DEVICES MARKET, BY REGION, 2019–2027($MILLION)
TABLE 54.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 55.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 56.NORTH AMERICA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 57.U.S. PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 58.U.S. PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 59.CANADA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 60.CANADA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 61.MEXICO PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 62.MEXICO PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 63.EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 64.EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 65.EUROPE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 66.GERMANY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 67.GERMANY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 68.FRANCE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 69.FRANCE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 70.UK PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 71.UK PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 72.ITALY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 73.ITALY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 74.SPAIN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 75.SPAIN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 76.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 77.REST OF EUROPE PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 78.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 79.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 80.ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 81.JAPAN PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 82.JAPAN PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 83.CHINA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 84.CHINA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 85.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 86.AUSTRALIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 87.INDIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 88.INDIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 89.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 90.SOUTH KOREA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 91.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 92.REST OF ASIA-PACIFIC PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 93.LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 94.LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 95.LAMEA PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019–2027($MILLION)
TABLE 96.BRAZIL PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 97.BRAZIL PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 98.TURKEY PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 99.TURKEY PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 100.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 101.VENEZUELA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 102.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 103.SAUDI ARABIA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 104.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY PRODUCT TYPE, 2019–2027($MILLION)
TABLE 105.REST OF LAMEA PATIENT MONITORING DEVICES MARKET, BY END USER, 2019–2027($MILLION)
TABLE 106.ABBOTT: COMPANY SNAPSHOT
TABLE 107.ABBOTT: OERATING SEGMENT
TABLE 108.ABBOTT: PRODUCT PORTFOLIO
TABLE 109.BIOTRONIK: COMPANY SNAPSHOT
TABLE 110.BIOTRONIK: OPERATING SEGMENTS
TABLE 111.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 112.GE: COMPANY SNAPSHOT
TABLE 113.GE: OPERATING SEGMENTS
TABLE 114.GE: PRODUCT PORTFOLIO
TABLE 115.ROCHE: COMPANY SNAPSHOT
TABLE 116.ROCHE: OERATING SEGMENT
TABLE 117.ROCHE: PRODUCT PORTFOLIO
TABLE 118.J&J: COMPANY SNAPSHOT
TABLE 119.J&J: OPERATING SEGMENTS
TABLE 120.J&J: PRODUCT PORTFOLIO
TABLE 121.PHILIPS: COMPANY SNAPSHOT
TABLE 122.PHILIPS: OPERATING SEGMENTS
TABLE 123.PHILIPS: PRODUCT PORTFOLIO
TABLE 124.MASIMO: COMPANY SNAPSHOT
TABLE 125.MASIMO: PRODUCT PORTFOLIO
TABLE 126.MEDTRONIC: COMPANY SNAPSHOT
TABLE 127.MEDTRONIC: OPERATING BUSINESS SEGMENTS
TABLE 128.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 129.NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 130.GSK: PRODUCT PORTFOLIO
TABLE 131.OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 132.OMRON CORPORATION: OPERATING SEGMENTS
TABLE 133.OMRON CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TOP INVESTMENT POCKETS: GLOBAL PATIENT MONITORING DEVICES MARKET, BY DEVICE TYPE
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017–2020*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020* (%)
FIGURE 05.TOP PLAYER POSITIONING
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF NEW ENTRANTS
FIGURE 09.MODERATE THREAT OF SUBSTITUTION
FIGURE 10.HIGH COMPETITIVE RIVALRY
FIGURE 11.PATENTS REGISTERED/APPROVED, 2011–2020
FIGURE 12.PATENTS REGISTERED/APPROVED, BY APPLICANTS, 2011–2020
FIGURE 13.U.S. PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 14.PCT PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 15.EUROPE PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 16.CHINA PATENT ANALYSIS, BY MARKET APPLICANTS, 2011–2020
FIGURE 17.AUSTRALIA PATENT ANALYSIS BY MARKET APPLICANTS, 2011–2020
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HEMODYNAMIC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF NEUROMONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF CARDIAC PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF FETAL AND NEONATAL MONITORING PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF RESPIRATORY PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF MULTIPARAMETER PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF REMOTE PATEINT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF WEIGHT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF TEMPERATURE PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF URINE OUTPUT PATIENT MONITORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOSPITAL PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 29.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF HOME SETTINGS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 30.COMPARATIVE SHARE ANALYSIS OF DELIVERY OF AMBULATORY SURGICAL CENTERS PATIENT MONTORING DEVICES MARKET, BY COUNTRY, 2019 & 2027(%)
FIGURE 31.ABBOTT: NET SALES, 2017–2019 ($MILLION)
FIGURE 32.ABBOTT: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 33.ABBOTT: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 34.GE: NET SALES, 2017–2019 ($MILLION)
FIGURE 35.GE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 36.GE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 37.ROCHE: NET SALES, 2017–2019 ($MILLION)
FIGURE 38.ROCHE: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 39.ROCHE: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 40.J&J: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.J&J: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.J&J: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.PHILIPS: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.PHILIPS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 45.PHILIPS: REVENUE SHARE, BY REGION, 2019(%)
FIGURE 46.MASIMO: NET SALES, 2017-2019 ($MILLION)
FIGURE 47.MASIMO: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 48.MEDTRONIC: NET SALES, 2017–2019 ($MILLION)
FIGURE 49.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 50.MEDTRONIC: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NIHON KOHDEN: NET SALES, 2016–2018 ($MILLION)
FIGURE 52.NIHON KOHDEN: REVENUE SHARE, BY PRODUCT SEGMENT, 2018 (%)
FIGURE 53.NIHON KOHDEN: REVENUE SHARE, BY REGION, 2018 (%)
FIGURE 54.OMRON CORPORATION: NET SALES, 2016–2018 ($MILLION)
FIGURE 55.OMRON CORPORATION: REVENUE SHARE, BY SEGMENT, 2018 (%)
FIGURE 56.OMRON CORPORATION: REVENUE SHARE, BY REGION, 2018 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[患者モニタリング用装置の世界市場2020–2027:製品別(血行動態モニタリング、神経モニタリング、心臓モニタリング、胎児・新生児モニタリング、呼吸モニタリング、マルチパラメーターモニタリング、リモート患者モニタリング、体重モニタリング、温度モニタリングデバイス)、エンドユーザー別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆